Canopy Growth – Will it Ever Recover?

Canopy Growth Corp stock has been tumbling for years. Can it ever recover?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth Corp (TSX:WEED) stock has been in a freefall for many years now. Starting in 2018, the stock crashed, and was setting new lows as recently as this year. As of this writing, WEED stock traded for $0.60, placing it squarely in the ‘penny stock‘ category. It was $51.83 at its all-time high.

It’s somewhat curious that Canopy’s big sell-off began in late 2018, just as marijuana legalization was being rolled out nationwide. The prevailing sentiment in 2017 and early 2018 was that legalization would boost marijuana stocks but, in fact, it seems to have held them back. It’s true that weed stocks saw a big revenue jump after cannabis was legalized. The problem was that their expenses grew even faster than their sales did. They also took some damage when acquisitions they had made proved worthless, leading to massive write-downs.

For the reasons outlined above, the last few years have been difficult for weed stocks. Their stock prices have declined, and their fundamentals have deteriorated. Now, however, they may have a chance to prove themselves. Trading for mere pennies, they are starting to look cheap. In this article, I will explore whether cannabis stocks can make a comeback, with a particular focus on Canopy Growth Corp.

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

Still losing money

One thing that’s abundantly clear about cannabis stocks is that they are still losing money.

In its most recent quarter, Canopy delivered:

  • -$2.4 million in gross margin.
  • A -$153 million operating loss.
  • A -$261 million net loss.

As you can see, Canopy was solidly unprofitable in its most recent quarter. Even the gross profit – the profit metric that factors in the fewest expenses – was negative. It would take a lot of growth for Canopy to become profitable at its current level of expenses. Unfortunately, the company isn’t growing at all.

Growth turns negative

In its most recent quarter, Canopy Growth Corp did $113 million in revenue, down 27% year over year. All of its negative profit metrics got even more negative; for example, net income went from -$108 million to -$261 million. So we’ve got Canopy here losing increasing amounts of money on lower revenue. Not a good-looking position, and it’s not clear that Canopy can right the ship in time to turn things around.

Hope for the future?

As we’ve seen, Canopy Growth Corp is shrinking, isn’t profitable, and is seeing ever-widening losses. Certainly, things aren’t looking good. But could there be some encouraging signs, too?

Arguably, yes. WEED stock is by some metrics cheap at today’s prices. It trades just 0.8 times sales and 0.28 times book value. This is far cheaper than the vast majority of stocks you will find out there. However, the company’s sales are declining, and rapidly. The optical cheapness at today’s levels may not hold up in the future.

Foolish takeaway

Canopy Growth Corp stock hasn’t been doing well lately, and it’s no surprise, because the company hasn’t been doing well either. It is shrinking, and its losses are ballooning. Potentially, there is a “deep value” play buried in here at some level. But I personally wouldn’t go looking for it.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »